Published in Proc Natl Acad Sci U S A on October 17, 2007
Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses. PLoS Pathog (2013) 1.83
An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism. PLoS Pathog (2016) 1.60
Crystal structure of unliganded influenza B virus hemagglutinin. J Virol (2008) 1.24
Viruses and sialic acids: rules of engagement. Curr Opin Struct Biol (2011) 1.21
Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry. PLoS Pathog (2012) 1.11
The contrasting phylodynamics of human influenza B viruses. Elife (2015) 1.10
Structural basis for the divergent evolution of influenza B virus hemagglutinin. Virology (2013) 0.94
Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014. PLoS One (2015) 0.88
Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y. Antimicrob Agents Chemother (2014) 0.88
Human monoclonal antibodies broadly neutralizing against influenza B virus. PLoS Pathog (2013) 0.86
Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014. PLoS One (2015) 0.85
Comparison of the Infectivity and Transmission of Contemporary Canine and Equine H3N8 Influenza Viruses in Dogs. Vet Med Int (2013) 0.85
Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181. J Antimicrob Chemother (2010) 0.84
Colorimetric viral detection based on sialic acid stabilized gold nanoparticles. Biosens Bioelectron (2012) 0.82
Morphology of influenza B/Lee/40 determined by cryo-electron microscopy. PLoS One (2014) 0.81
Structural insights into the membrane fusion mechanism mediated by influenza virus hemagglutinin. Biochemistry (2014) 0.79
Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors. Glycoconj J (2010) 0.79
Culturing of respiratory viruses in well-differentiated pseudostratified human airway epithelium as a tool to detect unknown viruses. Influenza Other Respir Viruses (2014) 0.77
The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus. Virology (2013) 0.76
A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action. Nat Commun (2017) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol (1999) 7.89
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology (1983) 7.26
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A (2001) 5.92
Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology (1997) 4.96
Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology (1991) 4.85
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Receptor binding properties of human and animal H1 influenza virus isolates. Virology (1989) 3.98
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J Virol (1984) 3.11
Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry (1992) 3.03
Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science (2007) 2.95
Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A (1982) 2.86
An avian influenza H5N1 virus that binds to a human-type receptor. J Virol (2007) 2.77
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology (1997) 2.51
Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol (1997) 2.38
A solid-phase enzyme-linked assay for influenza virus receptor-binding activity. J Virol Methods (1992) 2.32
Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology (1999) 2.31
Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology (1993) 2.27
X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology (2003) 2.23
Evolutionary changes in influenza B are not primarily governed by antibody selection. Proc Natl Acad Sci U S A (1990) 2.11
Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology (1998) 1.95
Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. J Biol Chem (1985) 1.91
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci U S A (1983) 1.88
Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J Gen Virol (1992) 1.69
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology (2002) 1.57
Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs. Structure (1994) 1.24
Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains. Virology (1992) 1.18
Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences. J Clin Microbiol (2000) 1.14
Emergence of an influenza B virus with antigenic change. J Clin Microbiol (2002) 1.05
Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season. J Clin Microbiol (2004) 0.98
Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol (2004) 0.95
Use of sialic acid analogues to define functional groups involved in binding to the influenza virus hemagglutinin. Eur J Biochem (1992) 0.92
The location of the bromelain cleavage site in a Hong Kong influenza virus Haemagglutinin. J Gen Virol (1981) 0.86
Human influenza virus recognition of sialyloligosaccharides. FEBS Lett (1995) 0.86
Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999. Arch Virol (2001) 0.85
Homology model of the structure of influenza B virus HA1. J Gen Virol (2004) 0.82
Specificity of sialyl-sugar chain mediated recognition by the hemagglutinin of human influenza B virus isolates. J Biochem (1994) 0.76
A novel strain, B/Gifu/2/73, differs from other influenza B viruses in the receptor binding specificities toward sialo-sugar chain linkage. Biochem Biophys Res Commun (1996) 0.76
Band gap fluorescence from individual single-walled carbon nanotubes. Science (2002) 5.34
Experimental verification of conformational variation of human fatty acid synthase as predicted by normal mode analysis. Structure (2004) 2.30
How to describe protein motion without amino acid sequence and atomic coordinates. Proc Natl Acad Sci U S A (2002) 2.06
Structure of the full-length Shaker potassium channel Kv1.2 by normal-mode-based X-ray crystallographic refinement. Proc Natl Acad Sci U S A (2010) 2.02
The crystal structure of murine p97/VCP at 3.6A. J Struct Biol (2003) 1.98
A normal mode analysis of structural plasticity in the biomolecular motor F(1)-ATPase. J Mol Biol (2004) 1.92
(E)-4-[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino-meth-yl]phenyl 4-bromo-benzene-sulfonate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.67
Conformational pathways in the gating of Escherichia coli mechanosensitive channel. Proc Natl Acad Sci U S A (2002) 1.56
The role of shape in determining molecular motions. Biophys J (2005) 1.53
Normal mode refinement of anisotropic thermal parameters for a supramolecular complex at 3.42-A crystallographic resolution. Proc Natl Acad Sci U S A (2007) 1.52
OPUS-PSP: an orientation-dependent statistical all-atom potential derived from side-chain packing. J Mol Biol (2007) 1.48
Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918. PLoS One (2009) 1.40
Domain movements in human fatty acid synthase by quantized elastic deformational model. Proc Natl Acad Sci U S A (2002) 1.38
Motions and negative cooperativity between p97 domains revealed by cryo-electron microscopy and quantised elastic deformational model. J Mol Biol (2003) 1.36
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. J Clin Invest (2007) 1.34
A Structural-informatics approach for tracing beta-sheets: building pseudo-C(alpha) traces for beta-strands in intermediate-resolution density maps. J Mol Biol (2004) 1.34
Cross-coupling reactions of aryl pivalates with boronic acids. J Am Chem Soc (2008) 1.33
OPUS-Ca: a knowledge-based potential function requiring only Calpha positions. Protein Sci (2007) 1.33
A New Method for Coarse-Grained Elastic Normal-Mode Analysis. J Chem Theory Comput (2006) 1.32
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy. Circulation (2007) 1.28
Conformational transition of amyloid beta-peptide. Proc Natl Acad Sci U S A (2005) 1.28
Ligand-free and -bound structures of the binding protein (LivJ) of the Escherichia coli ABC leucine/isoleucine/valine transport system: trajectory and dynamics of the interdomain rotation and ligand specificity. Biochemistry (2005) 1.26
Crystal structure of unliganded influenza B virus hemagglutinin. J Virol (2008) 1.24
Intrinsic flexibility and gating mechanism of the potassium channel KcsA. Proc Natl Acad Sci U S A (2002) 1.22
Normal-mode refinement of anisotropic thermal parameters for potassium channel KcsA at 3.2 A crystallographic resolution. Structure (2007) 1.20
Simulation via direct computation of partition functions. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 1.17
A structural-informatics approach for mining beta-sheets: locating sheets in intermediate-resolution density maps. J Mol Biol (2003) 1.13
11-(p-Tolylsulfonyl)-8,14,24-trioxa-11,22,23-triazatetracyclo[19.2.1.0.0]tetracosa-1(23),2,4,6,15,17,19,21-octaene. Acta Crystallogr Sect E Struct Rep Online (2009) 1.07
Substructure synthesis method for simulating large molecular complexes. Proc Natl Acad Sci U S A (2002) 1.07
Refinement of F-actin model against fiber diffraction data by long-range normal modes. Biophys J (2004) 1.06
OPUS-Rota: a fast and accurate method for side-chain modeling. Protein Sci (2008) 1.06
Protein structural transitions and their functional role. Philos Trans A Math Phys Eng Sci (2005) 1.05
The unfolding action of GroEL on a protein substrate. Biophys J (2004) 1.04
Allosteric transition pathways in the lactose repressor protein core domains: asymmetric motions in a homodimer. Protein Sci (2003) 1.03
Simulation of F-actin filaments of several microns. Biophys J (2003) 1.01
The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats. PLoS One (2012) 1.00
Dissecting the streptavidin-biotin interaction by phage-displayed shotgun scanning. Chembiochem (2002) 1.00
Counting solutions for the N -queens and Latin-square problems by Monte Carlo simulations. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.00
A minimalist network model for coarse-grained normal mode analysis and its application to biomolecular x-ray crystallography. Proc Natl Acad Sci U S A (2008) 0.99
The allosteric mechanism of yeast chorismate mutase: a dynamic analysis. J Mol Biol (2005) 0.98
Structural improvement of unliganded simian immunodeficiency virus gp120 core by normal-mode-based X-ray crystallographic refinement. Acta Crystallogr D Biol Crystallogr (2009) 0.98
Serine 88 phosphorylation of the 8-kDa dynein light chain 1 is a molecular switch for its dimerization status and functions. J Biol Chem (2007) 0.97
Comparison of sampling efficiency between simulated tempering and replica exchange. J Chem Phys (2008) 0.97
Enhanced sampling and applications in protein folding in explicit solvent. J Chem Phys (2010) 0.97
Folding of small helical proteins assisted by small-angle X-ray scattering profiles. Structure (2005) 0.96
Conformational flexibility of pyruvate dehydrogenase complexes: a computational analysis by quantized elastic deformational model. J Mol Biol (2003) 0.95
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase. Proc Natl Acad Sci U S A (2013) 0.93
Unfolding of heptameric co-chaperonin protein follows "fly casting" mechanism: observation of transient nonnative heptamer. J Am Chem Soc (2005) 0.92
Determining protein topology from skeletons of secondary structures. J Mol Biol (2005) 0.91
The conformational coupling and translocation mechanism of vitamin B12 ATP-binding cassette transporter BtuCD. Biophys J (2007) 0.91
Molecular dynamics analysis of a buckyball-antibody complex. Proc Natl Acad Sci U S A (2002) 0.90
Folding helical proteins in explicit solvent using dihedral-biased tempering. Proc Natl Acad Sci U S A (2012) 0.89
Application of normal-mode refinement to X-ray crystal structures at the lower resolution limit. Acta Crystallogr D Biol Crystallogr (2009) 0.89
Theoretical analysis of twist/bend ratio and mechanical moduli of bacterial flagellar hook and filament. Biophys J (2004) 0.88
Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide. Biochemistry (2006) 0.88
Molecular docking study of the interactions between the thioesterase domain of human fatty acid synthase and its ligands. Proteins (2008) 0.88
Diversifying selective pressure on influenza B virus hemagglutinin. J Med Virol (2009) 0.87
(E)-1,5-Dimethyl-4-[3-(4-nitro-benz-yloxy)benzyl-ideneamino]-2-phenyl-1H-pyrazol-3(2H)-one. Acta Crystallogr Sect E Struct Rep Online (2008) 0.87
Protective effects of nizofenone administration on the cognitive impairments induced by chronic restraint stress in mice. Pharmacol Biochem Behav (2012) 0.85
Normal mode analysis with molecular geometry restraints: bridging molecular mechanics and elastic models. Arch Biochem Biophys (2011) 0.85
Structural basis of actin filament nucleation by tandem W domains. Cell Rep (2013) 0.84
Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension. PLoS One (2011) 0.84
Sudden death due to traumatic ascending aortic pseudoaneurysms ruptured into the esophagus: 2 case reports. Medicine (Baltimore) (2015) 0.84
Pre-existing diseases of patients increase susceptibility to hypoxemia during gastrointestinal endoscopy. PLoS One (2012) 0.84
Effect of inorganic phosphate on FMN binding and loop flexibility in Desulfovibrio desulfuricans apo-flavodoxin. J Mol Biol (2005) 0.83
OPUS-Dom: applying the folding-based method VECFOLD to determine protein domain boundaries. J Mol Biol (2008) 0.83
Enhanced sampling in generalized ensemble with large gap of sampling parameter: case study in temperature space random walk. J Chem Phys (2009) 0.83
Genome-wide polycomb target gene prediction in Drosophila melanogaster. Nucleic Acids Res (2012) 0.83
Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s. J Biol Chem (2006) 0.82
Protective effect of l-citrulline against ethanol-induced gastric ulcer in rats. Environ Toxicol Pharmacol (2012) 0.81
Rhodiola: an ordinary plant or a promising future therapy for pulmonary hypertension? a brief review. Pulm Circ (2013) 0.81
Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling. Int J Cardiol (2012) 0.80
Beneficial synergistic effects of concurrent treatment with theanine and caffeine against cerebral ischemia-reperfusion injury in rats. Can J Physiol Pharmacol (2013) 0.80
Correlation between protein stability cores and protein folding kinetics: a case study on Pseudomonas aeruginosa apo-azurin. Structure (2006) 0.80
Phase transition of nanotube-confined water driven by electric field. J Chem Phys (2011) 0.80
Asymmetric conformational flexibility in the ATP-binding cassette transporter HI1470/1. Biophys J (2009) 0.79
Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)? Cell Res (2009) 0.79
Estimating statistical distributions using an integral identity. J Chem Phys (2012) 0.79
Structural insights into the membrane fusion mechanism mediated by influenza virus hemagglutinin. Biochemistry (2014) 0.79
Synthesis of tetraphenyl-substituted [12]cycloparaphenylene: toward a rationally designed ultrashort carbon nanotube. J Org Chem (2012) 0.78
Predicting protein folding cores by empirical potential functions. Arch Biochem Biophys (2008) 0.78
A computational analysis of ATP binding of SV40 large tumor antigen helicase motor. PLoS Comput Biol (2009) 0.78
Altering residues N125 and D149 impacts sugar effector binding and allosteric parameters in Escherichia coli lactose repressor. Biochemistry (2011) 0.78
PIM: phase integrated method for normal mode analysis of biomolecules in a crystalline environment. J Mol Biol (2013) 0.77
Correlations between event-related potentials with pictures recognition and WMS-RC scores in patients with memory disorder caused by severe traumatic brain injury. J Huazhong Univ Sci Technolog Med Sci (2008) 0.77
[Inhibitory effect of valproic acid on xenografted Kasumi-1 tumor growth in nude mouse and its mechanism]. Zhonghua Xue Ye Xue Za Zhi (2011) 0.76
Luteolin attenuates diabetes-associated cognitive decline in rats. Brain Res Bull (2013) 0.76
Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors. Onco Targets Ther (2013) 0.76
fSUB: normal mode analysis with flexible substructures. J Phys Chem B (2012) 0.76
Immunogenicity and protective efficacy study using combination of four tuberculosis DNA vaccines. Sci China C Life Sci (2003) 0.76
Polymer-Lipid Hybrid Theranostic Nanoparticles Co-Delivering Ultrasmall Superparamagnetic Iron Oxide and Paclitaxel for Targeted Magnetic Resonance Imaging and Therapy in Atherosclerotic Plaque. J Biomed Nanotechnol (2016) 0.76
[Combined recombinant DNA vaccine results in significant protection against Mycobacterium tuberculosis]. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) (2003) 0.76
Protective effects of luteolin on cognitive impairments induced by psychological stress in mice. Exp Biol Med (Maywood) (2013) 0.76
Who are the users of a traditional Chinese sanfu acupoint herbal patching therapy in China?: A cross-sectional survey. Medicine (Baltimore) (2016) 0.75
(Anthracen-9-ylmeth-yl)benzyl-ammonium chloride. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
2,5-Bis[2-(2-methoxy-ethoxy)phen-yl]-1,3,4-oxadiazole. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75